These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 22289620)

  • 1. Dose-escalation using intensity-modulated radiotherapy for prostate cancer - evaluation of quality of life with and without (18)F-choline PET-CT detected simultaneous integrated boost.
    Pinkawa M; Piroth MD; Holy R; Klotz J; Djukic V; Corral NE; Caffaro M; Winz OH; Krohn T; Mottaghy FM; Eble MJ
    Radiat Oncol; 2012 Jan; 7():14. PubMed ID: 22289620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensity-modulated radiotherapy of prostate cancer with simultaneous integrated boost after molecular imaging with 18F-choline-PET/CT : Clinical results and quality of life.
    Schlenter M; Berneking V; Krenkel B; Mottaghy FM; Vögeli TA; Eble MJ; Pinkawa M
    Strahlenther Onkol; 2018 Jul; 194(7):638-645. PubMed ID: 29511777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensity-modulated radiotherapy for prostate cancer implementing molecular imaging with 18F-choline PET-CT to define a simultaneous integrated boost.
    Pinkawa M; Holy R; Piroth MD; Klotz J; Nussen S; Krohn T; Mottaghy FM; Weibrecht M; Eble MJ
    Strahlenther Onkol; 2010 Nov; 186(11):600-6. PubMed ID: 20936457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-escalation using intensity-modulated radiotherapy for prostate cancer--evaluation of the dose distribution with and without 18F-choline PET-CT detected simultaneous integrated boost.
    Pinkawa M; Attieh C; Piroth MD; Holy R; Nussen S; Klotz J; Hawickhorst R; Schäfer W; Eble MJ
    Radiother Oncol; 2009 Nov; 93(2):213-9. PubMed ID: 19717197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18F-choline PET/CT.
    Kuang Y; Wu L; Hirata E; Miyazaki K; Sato M; Kwee SA
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1017-25. PubMed ID: 25832692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of androgen deprivation therapy on intraprostatic tumour volume identified on
    Chan J; Carver A; Brunt JN; Vinjamuri S; Syndikus I
    Br J Radiol; 2017 Mar; 90(1071):20160818. PubMed ID: 27993093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensity-modulated salvage radiotherapy with simultaneous integrated boost for local recurrence of prostate carcinoma: a pilot study on the place of PET-choline for guiding target volume delineation.
    Wahart A; Guy JB; Vallard A; Geissler B; Ben Mrad M; Falk AT; Prevot N; de Laroche G; Rancoule C; Chargari C; Magné N
    Br J Radiol; 2016; 89(1058):20150579. PubMed ID: 26648528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [18F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes.
    Würschmidt F; Petersen C; Wahl A; Dahle J; Kretschmer M
    Radiat Oncol; 2011 May; 6():44. PubMed ID: 21529377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (11)C-Choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients.
    Picchio M; Berardi G; Fodor A; Busnardo E; Crivellaro C; Giovacchini G; Fiorino C; Kirienko M; Incerti E; Messa C; Gianolli L; Di Muzio N
    Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1270-9. PubMed ID: 24599378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of Life Changes >10 Years After Postoperative Radiation Therapy After Radical Prostatectomy for Prostate Cancer.
    Leufgens F; Berneking V; Vögeli TA; Kirschner-Hermanns R; Eble MJ; Pinkawa M
    Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):382-388. PubMed ID: 31201895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity modulated radiation therapy dose painting for localized prostate cancer using ¹¹C-choline positron emission tomography scans.
    Chang JH; Lim Joon D; Lee ST; Gong SJ; Anderson NJ; Scott AM; Davis ID; Clouston D; Bolton D; Hamilton CS; Khoo V
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e691-6. PubMed ID: 22658218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer.
    Pinkawa M; Piroth MD; Holy R; Djukic V; Klotz J; Krenkel B; Eble MJ
    Strahlenther Onkol; 2011 Aug; 187(8):479-84. PubMed ID: 21789739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer.
    Fodor A; Berardi G; Fiorino C; Picchio M; Busnardo E; Kirienko M; Incerti E; Dell'Oca I; Cozzarini C; Mangili P; Pasetti M; Calandrino R; Gianolli L; Di Muzio NG
    BJU Int; 2017 Mar; 119(3):406-413. PubMed ID: 27104782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer.
    Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Thomas L; Kantz S; Hung A; Monaco D; Gaertner FC; Essler M; Strunk H; Laub W; Bundschuh RA
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1170-1178. PubMed ID: 29468311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal dose escalation for prostate cancer using
    Zamboglou C; Thomann B; Koubar K; Bronsert P; Krauss T; Rischke HC; Sachpazidis I; Drendel V; Salman N; Reichel K; Jilg CA; Werner M; Meyer PT; Bock M; Baltas D; Grosu AL
    Radiat Oncol; 2018 May; 13(1):81. PubMed ID: 29716617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choline PET based dose-painting in prostate cancer--modelling of dose effects.
    Niyazi M; Bartenstein P; Belka C; Ganswindt U
    Radiat Oncol; 2010 Mar; 5():23. PubMed ID: 20298546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-targeted dose escalation for localized prostate cancer using MR-guided HDR brachytherapy (HDR) or integrated VMAT (IB-VMAT) boost: Dosimetry, toxicity and health related quality of life.
    Sanmamed N; Lee J; Berlin A; Craig T; Lao B; Rink A; Bayley A; Catton C; Sundaramurthy A; Foltz W; McPartlin A; Ghai S; Astenafu E; Gospodarowicz M; Warde P; Ménard C; Chung P
    Radiother Oncol; 2020 Aug; 149():240-245. PubMed ID: 32447033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose escalation in prostate radiotherapy up to 82 Gy using simultaneous integrated boost: direct comparison of acute and late toxicity with 3D-CRT 74 Gy and IMRT 78 Gy.
    Dolezel M; Odrazka K; Vaculikova M; Vanasek J; Sefrova J; Paluska P; Zouhar M; Jansa J; Macingova Z; Jarosova L; Brodak M; Moravek P; Hartmann I
    Strahlenther Onkol; 2010 Apr; 186(4):197-202. PubMed ID: 20354663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.